compounded semaglutide lawsuit news today The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the Hims & Hers Health and

Sitting Still RLS can flare up when youre forced to sit for long periods of time and can't get up

Eli Lilly, which sells Zepbound and Mounjaro, just released a blockbuster Q2 this morning, beating Wall Street projections and raising its 2025 sales guidance

Weight loss that feels, for the first time, sustainable

When you pay money, stick a visible patch on your arm, and start monitoring your eating, the act itself changes behavior

And understand that realistic retatrutide results after 40 require all four of these to be working together

This is called prior authorization, and it means your doctor will need to submit a form to your insurance company showing that Ozempic is "medically necessary" for your health